Evidence map›Paper›PMID 28073831›Full record

ArticleDiabetes2017

Deletion of Protein Kinase C λ in POMC Neurons Predisposes to Diet-Induced Obesity.

Mauricio D Dorfman, Jordan E Krull, Jarrad M Scarlett, Stephan J Guyenet, Mini P Sajan, Vincent Damian, Hong T Nguyen, Michael Leitges, Gregory J Morton, Robert V Farese and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Mauricio D DorfmanUW Diabetes Institute and Department of Medicine, University of Washington, Seattle, WA.
Jordan E KrullUW Diabetes Institute and Department of Medicine, University of Washington, Seattle, WA.
Jarrad M ScarlettUW Diabetes Institute and Department of Medicine, University of Washington, Seattle, WA.
Stephan J GuyenetUW Diabetes Institute and Department of Medicine, University of Washington, Seattle, WA.
Mini P SajanDepartment of Internal Medicine, University of South Florida College of Medicine, Tampa, FL.
Vincent DamianUW Diabetes Institute and Department of Medicine, University of Washington, Seattle, WA.
Hong T NguyenUW Diabetes Institute and Department of Medicine, University of Washington, Seattle, WA.
Michael LeitgesThe Biotechnology Centre of Oslo, University of Oslo, Oslo, Norway.
Gregory J MortonUW Diabetes Institute and Department of Medicine, University of Washington, Seattle, WA.
Robert V FareseDepartment of Internal Medicine, University of South Florida College of Medicine, Tampa, FL.
Michael W SchwartzUW Diabetes Institute and Department of Medicine, University of Washington, Seattle, WA.
Joshua P ThalerUW Diabetes Institute and Department of Medicine, University of Washington, Seattle, WA jpthaler@uw.edu.
University of Washington · USFlorida College · USUniversity of Oslo · NOUniversity of South Florida · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Tomas Vaisar · 1986 to 2026
$41.4M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI Ellen A Schur · 1986 to 2026
$30.4M
Novel Brain Mechanisms Controlling Glucose HomeostasisR01DK083042 · NIDDK · UNIVERSITY OF WASHINGTON · PI SCHWARTZ, MICHAEL W · 2008 to 2025
$7.6M
Nutrition, Obesity and Atherosclerosis Training ProgramT32HL007028 · NHLBI · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1985 to 2026
$6.4M
Neuroendocrine Control of Glucose MetabolismR01DK089056 · NIDDK · UNIVERSITY OF WASHINGTON · PI MORTON, GREGORY J · 2011 to 2024
$5.6M
NEUROENDOCRINE REGULATION OF ENERGY BALANCER01DK052989 · NIDDK · UNIVERSITY OF WASHINGTON · PI SCHWARTZ, MICHAEL W · 1997 to 2011
$3.3M
Novel Anti-Diabetic Actions of Hypothalamic FGF19-FGFR1 SignalingR01DK101997 · NIDDK · UNIVERSITY OF WASHINGTON · PI SCHWARTZ, MICHAEL W · 2014 to 2018
$1.9M
Cellular Mechanisms of Hypothalamic Inflammation in High Fat Diet-Induced ObesityK08DK088872 · NIDDK · UNIVERSITY OF WASHINGTON · PI THALER, JOSHUA P · 2010 to 2014
$746k
NHLBI NIH HHS T32 HL007028NIDDK NIH HHS K08 DK088872NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK035816NIDDK NIH HHS R01 DK052989NIDDK NIH HHS R01 DK083042NIDDK NIH HHS R01 DK089056NIDDK NIH HHS R01 DK101997
6 · The paper itself

Abstract

Effectors of the phosphoinositide 3-kinase (PI3K) signal transduction pathway contribute to the hypothalamic regulation of energy and glucose homeostasis in divergent ways. Here we show that central nervous system (CNS) action of the PI3K signaling intermediate atypical protein kinase C (aPKC) constrains food intake, weight gain, and glucose intolerance in both rats and mice. Pharmacological inhibition of CNS aPKC activity acutely increases food intake and worsens glucose tolerance in chow-fed rodents and causes excess weight gain during high-fat diet (HFD) feeding. Similarly, selective deletion of the aPKC isoform

Indexed as

AnimalsDiet, High-FatEatingEnergy MetabolismGlucoseGlucose IntoleranceHypothalamusInsulin ResistanceIsoenzymesLeptinMaleMelanocortinsMiceNeuronsObesityParaventricular Hypothalamic NucleusGlucoseIsoenzymesLeptinMelanocortinsPhosphatidylinositol 3-KinasesPKC-3 proteinPro-OpiomelanocortinProtein Kinase CProtein Kinase C-lambda

Identifiers

PMID28073831
PMCPMC5360303
OpenAlexW2569882343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.